Theravance Biopharma (TBPH) Divestments (2020 - 2022)
Theravance Biopharma (TBPH) reported Divestments of -$1.1 billion for Q4 2022, down 7416.0% quarter-over-quarter from $14.9 million in Q1 2020.
Theravance Biopharma (TBPH) Divestments (2020 - 2022) Analysis & Trends
Theravance Biopharma (TBPH) has 2 years of Divestments data on file, last reported at -$1.1 billion in Q4 2022.
- Divestments for Q4 2022 came in at -$1.1 billion, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was -$1.1 billion (changed N/A YoY), and the FY2022 annual result was $2.7 million, changed N/A from the prior year.
- Divestments eased to -$1.1 billion in Q4 2022 per TBPH's latest filing, from $14.9 million in the prior quarter.
- Over five years, Divestments peaked at $14.9 million in Q1 2020 and troughed at -$1.1 billion in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Theravance Biopharma | 835.85 Mn | 441.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -1.09 Bn |
| Mar 31, 2020 | 14.93 Mn |